Safedalfa 1 mg 30 cap

Indications: Osteoporosis: Management and prevention of bone loss. Renal Osteodystrophy: Bone disease associated with chronic kidney failure. Hypoparathyroidism: Low parathyroid hormone levels, leading to low blood calcium. Hypophosphataemic Rickets/Osteomalacia: Bone disorders due to low phosphate levels. Post-menopausal Osteoporosis: To prevent and treat bone thinning after menopause.